REGISTRATION OPEN!

We are hosting our #EquityInIBD Hybrid Patient Symposium focused on the Black Indigenous People of Color (BIPOC) Patient community, on Sept 18th. This is the first patient symposium of its kind.

 

We are excited to extend opportunities that will increase education, awareness and disease management to our community. 

If your answer is YES to any of these questions:

  • Are you interested in decreasing disparities? 

  • Are you interested in engaging with REAL patients? 

  • Are you interested in learning more about IBD and the presentations in black and diverse patient populations?

  • Are you a patient who is looking for more answers and resources?

  •  Are you a care partner who is in need of support with navigating healthcare within IBD?

  • Are you concerned about clinical trials and research?

  • Are you a clinician working in equity?

  • Are you looking to network with other patient leaders, advocacy organizations, and industry leaders?

You should be here! 

Attend the Main Session or Join us at Table Talks:

  • Celiac Disease

  • Irritable Bowel Syndrome

  • Medical Nutrition Therapy (MNT)

  • Mental Health & Digestive Disease

  • Pediatric Gastroenterology

  • Understanding Disability (SSDI)

Details

EquityInIBD%20Patient%20Symposium_edited

Location:
Hilton Washington DC National Mall The Wharf
480 L'Enfant Plaza SW
Washington, DC
20024

Date: September 18th, 2021

Hybrid Event (Virtual & Onsite)

Our maximum onsite capacity with social distancing is 75 attendees

All Attendees are required to send proof of vaccination

**You will be able to schedule time at a table in July. 

REGISTRATION

OPENS 

MAY 19TH,

2021

EquityInIBD%20Patient%20Symposium_edited
PATIENT SYMPOSIUM.png

September 18th

IBD_edited.png
4.png

Announcements

IBD (2).png
We are excited to announce 
4.png
 

Partners

logo_size.jpg
gli logo 1.png
HAS-main-logo (1).png
logo-ghlf-logotype.png
Screenshot 2021-05-09 at 8.02.23 PM.png
0.png
Beyond_Celiac_Logo.jpg
PRLogoRGB-300x150.png
CrohnsBanner.png
Copy of CCYANLarge.png
download-1.png
iffgd-logo-main.png
AA_Logo_Main.jpg
 

Sponsors

Johnson & Johnson aspires to help eradicate racial and social injustice as a public health threat by eliminating health inequities for people of color.


People First Culture
Cultivate one of the most diverse and inclusive workforces that inspires innovative healthcare solutions around the world.

Healthier Communities
Help close the racial mortality gap by investing in culturally competent community care models that create health outcomes for people of color.

Enduring Alliances
Lead and leverage J&J's powerful partnership network to combat racial and social health determinants.

Equity Architect

jsn_logo_jj_vert_color_cmyk_u-2.jpg

"Amgen is committed to understanding and working to help reduce long standing healthcare inequities, including in clinical trials, where communities of color are disproportionately represented. As Amgen’s CEO and Chairman, Bob Bradway, has stated, “Healthcare equity has been an elusive dream in our society, but it doesn’t have to be an elusive dream,” “We’re committed to working on it in the short-term and in the long-term, and we accept that this is likely to be a journey of a thousand miles but it’s one that we want to be part of"

Equity Collaborator

Amgen_2_Blue.jpg

Equity Collaborator

hollister-incorporated-logo-vector.png

"Amgen is committed to understanding and working to help reduce long standing healthcare inequities, including in clinical trials, where communities of color are disproportionately represented. As Amgen’s CEO and Chairman, Bob Bradway, has stated, “Healthcare equity has been an elusive dream in our society, but it doesn’t have to be an elusive dream,” “We’re committed to working on it in the short-term and in the long-term, and we accept that this is likely to be a journey of a thousand miles but it’s one that we want to be part of"

phrma_2012logo_cmyk.jpg

"PhRMA and the biopharmaceutical industry are committed to driving real change and improving health outcomes for patients in underserved communities. Equity is critical to the health and well-being of Black and Brown communities and it remains essential to a robust ecosystem of innovation. America’s biopharmaceutical companies are pushing for necessary systemic long-term change to better meet the needs of Black and Brown America including advancing policy solutions and research to better address health disparities and earning trust and addressing systemic issues that deter certain communities from participating in clinical trials, so that those who want to participate can."

Equity Contributor